Article Details
Retrieved on: 2022-06-22 11:26:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH), a global life sciences ... antibody discovery, synthetic biology, and rare cell isolation.
Article found on: www.prnewswire.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here